Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized 5-fluorouracil dosing in colorectal cancer
2009-015955-25Phase 4Completed
- Sponsor
- University Hospital
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluorouracil in colorectal cancer (CRC), sponsored by University Hospital. Primary endpoints: Interindividual variability in pharmacokinetics and dynamics, 5-fluorouracil plasma concentrations and 1 more. Started Feb 2010; status: completed.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2009-015955-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015955-25.